One of the greatest problems slowing such work is that researchers have found major complications in purifying cell mixtures, for instance to remove stem cells that can cause tumors from cells developed for use in medical treatments. But a group of Scripps Research scientists, working with colleagues in Japan, have developed a clever solution to this purification problem that should prove more reliable than other methods, safer, and perhaps 100 times cheaper.
The work appears in the current edition of the journal Cell Research.
Effective tricks for separating stem cells from other types are essential for many emerging medical treatments. These techniques begin with researchers inducing stem cells to take specific forms, or differentiate, for instance into nerve cells. These differentiated cells might then be used to repair a spinal cord injury. Other cells might enable a diabetic's body to produce adequate insulin.
A key problem is that in the differentiation process, at least some stem cells inevitably remain in their undifferentiated, or pluripotent, state. These cells can grow to form tumors in patients if injected along with differentiated cells, a concern that has already led the US Food and Drug Administration (FDA) to delay clinical trials for promising stem cell-based therapies.
A New Approach
To date, almost all attempts at purification have focused on developing antibodies—immune system attack cells—that can remove or destroy stem cells in mixtures. But this approach has had shortcomings. Effective antibodies are difficult and expensive to develop, and their use in medical therapies raises safety issues because they are produced in animals.
The Scripps Research team, led by Professor of Developmental Neurobiology Jeanne Loring, was looking for a new route to solve the purification and safety problems. The group recently began experimenting with chip-based tools known as lectin arrays. At various points on these devices, plant-produced proteins called lectins are attached. These lectins bind with specific sugars including some found on the surface of cells.
Working in the lab with cellular components, rather than whole cells, the Loring team first found that specific combinations of sugars and proteins known as glycoproteins on stem cells reliably bind to certain lectins. They were then able to exploit this connection to purify cell mixtures.
"When we discovered there was a specific binding pattern, we decided we should just go for it and see whether we could use the lectins to purify cells," said Yu-Chieh Wang, the first author of the research article. "We tested the idea and it works very well, and lectins are readily available and inexpensive."
After identifying the lectin that bound best with stem cells, the group took the work to the next level to show that they could actually separate out stem cells. To accomplish this, they first attached the lectin to tiny beads. Then they exposed these beads to mixtures of stem cells along with non-stem cells.
The researchers used a range of different types of both embryonic stem cells and induced pluripotent cells, which are embryonic stem cell-like cells that are produced by inserting certain genes into skin cells. They included cell lines from both Scripps Research and the labs of their collaborators in Japan and the United States.
In every case, the team found that the stem cells bound remarkably well to the beads, while the cells that washed past were almost all non-stem cells; this meant that both cell types could be collected separately for use in research or in treatments.
Possible uses for the new technique are essentially as numerous as those for stem cells themselves. Lectin purification could be used with any of a huge range of therapies currently in development. In addition to low cost and reliability, the lectins used are plant products, so they do not introduce the type of safety concerns that could arise from using antibodies that are produced by animal cells.
Even in more basic research, effective studies using stem or differentiated cells generally requires purification so that effects can be identified and tracked without introducing complications from impurities in a group of cells.
Loring's group, for instance, is studying the production of nerve cells that might be used to treat a specific type of autism caused by a known genetic mutation. Producing the nerve cells needed is a laborious process that will be more efficient with better purification.
The Loring team is also working to identify different binding patterns that would allow them to similarly purify mixtures of specific types of non-stem cells. "In theory, this should allow us to pull any cell type out of any mixture," she said of the basic lectin technique.
At the more basic research level, because all the different stem cell lines from both humans and animals seem to produce similar glycoproteins binding to the lectins, it is possible these glycoproteins infer some basic qualities fundamental to the pluripotent state. Loring and her colleagues are exploring this possibility in hopes of better understanding stem cells' still mysterious abilities to transform into any type of cell. "We may have uncovered something really fundamental about pluripotency," said Loring.
This research was supported by the Marie Mayer Foundation, the California Institute for Regenerative Medicine, the National Institutes of Health, the Esther O'Keeffe Foundation, and the Hartwell Foundation.
In addition to Loring, authors on the paper, titled "Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis," were Yu-Chieh Wang, Ibon Garitaonandia, Ileana Slavin, Gulsah Altun, Robert Lacharite, Kristopher Nazor, Ha Tran, Candace Lynch, Trevor Leonardo, and Suzanne Peterson of Scripps Research; Ying Liu and Louise Laurent of Scripps Research and UCSD; Masato Nakagawa of the Center for iPS Cell Research and Application (CiRA), Kyoto University; and Shinya Yamanaka of CiRA and the Gladstone Institute of Cardiovascular Disease in San Francisco. For more information, see http://www.cell-research.com/AOP/September-6-4.htm .
Mika Ono | EurekAlert!
Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel
Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)
The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.
Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
25.05.2018 | Event News
02.05.2018 | Event News
13.04.2018 | Event News
25.05.2018 | Event News
25.05.2018 | Machine Engineering
25.05.2018 | Life Sciences